19
Participants
Start Date
February 28, 2013
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
Rituximab Infusion
Participants will receive their first infusion of rituximab at the standard infusion rate provided in the manufacturer labeling. If they tolerate this infusion with a grade 2 of less infusion-related reaction, the next infusion will be administered as a 90 minute rapid infusion.
Wake Forest Baptist Medical Center, Winston-Salem
Wake Forest University Health Sciences
OTHER